iodixanol has been researched along with Renal Insufficiency in 25 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In order to compare the effects of iopromide and isoxazole on postoperative contrast-induced nephropathy in patients with renal insufficiency, the paper searches for randomized controlled trials and retrospective cohort studies comparing the effects of iopromide and iodixanol on renal function in patients with renal insufficiency after surgery." | 9.22 | Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis. ( Duan, Z; Feng, Y; Hu, W; Li, P; Qiu, G; Wang, L; Wang, M; Xu, C; Zhou, H, 2022) |
| "Renal Insufficiency Following Radiocontrast Exposure demonstrates a homogeneously low rate of CIN after exposure to nonionic, iso-osmolar iodixanol regardless of the use of either bicarbonate sodium or sodium chloride solution for volume supplementation." | 9.13 | Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. ( Adolph, E; Chatterjee, T; Holdt-Lehmann, B; Ince, H; Koerber, T; Nienaber, CA; Paschka, S; Prott, A; Schneider, H; Schuff-Werner, P; Steiner, M, 2008) |
| " We investigated to determine whether simvastatin pretreatment reduces the risk of contrast-induced nephropathy in a high-risk population of patients with renal insufficiency undergoing coronary angiography." | 9.13 | Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study. ( Chae, IH; Cho, YS; Choi, DJ; Choi, YS; Chung, WY; Jo, SH; Kang, HJ; Kim, HS; Kim, YJ; Koo, BK; Oh, BH; Park, JS; Park, YB; Sohn, DW; Youn, TJ, 2008) |
| " This double blind, comparative, randomized, parallel trial compared the efficacy of iodixanol (non-ionic dimer) and iopromide (non-ionic monomer) in 100 patients with mild to moderate renal insufficiency (serum creatinine of 135 to 265 mumol l-1) who underwent i." | 9.08 | Comparison between the efficacy of dimeric and monomeric non-ionic contrast media (iodixanol vs iopromide) in urography in patients with mild to moderate renal insufficiency. ( Assante, M; Cova, M; Haider, T; Hougens Grynne, B; Stacul, F, 1998) |
| " The objective of our meta-analysis was to compare the clinical safety of iso-osmolar contrast medium iodixanol to low-osmolar contrast medium iopromide in patients with renal insufficiency undergoing coronary angiography with or without percutaneous coronary intervention (PCI)." | 8.98 | Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI. ( Chen, M; Jiang, Y; Rui, Q; Yang, H; Zhang, J; Zhang, N; Zhou, Y, 2018) |
| "The combined prophylactic strategy of sodium bicarbonate plus N-acetylsyteine (NAC) seems to be effective in preventing contrast induced acute kidney injury (CI-AKI) in patients at low-to-medium risk." | 6.25 | Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design. ( Briguori, C; Condorelli, G; Ricciardelli, B; Visconti, G, 2011) |
| "Gadolinium contrast is a potential alternative to iodinated contrast for percutaneous transluminal renal angioplasty (PTRA), and appears to be safe and well tolerated." | 5.35 | Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. ( Garovic, VD; Kalnicka, D; Kane, GC; Lee, CU; Rosenthal, DW; Stanson, AW; Textor, SC, 2008) |
| "In order to compare the effects of iopromide and isoxazole on postoperative contrast-induced nephropathy in patients with renal insufficiency, the paper searches for randomized controlled trials and retrospective cohort studies comparing the effects of iopromide and iodixanol on renal function in patients with renal insufficiency after surgery." | 5.22 | Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis. ( Duan, Z; Feng, Y; Hu, W; Li, P; Qiu, G; Wang, L; Wang, M; Xu, C; Zhou, H, 2022) |
| " In 562 evaluable patients (of 592 recruited), the contrast volume, presence of diabetes mellitus, mean baseline SCr and estimated glomerular filtration rate (eGFR) were comparable between the iopromide- and iodixanol-treated groups." | 5.16 | Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study. ( Chen, Y; Fu, G; Gao, C; Gao, W; He, B; He, Q; Hu, S; Liu, H; Liu, S; Liu, Y; Qi, X; Qiu, C; Su, X; Wang, J; Wang, L; Wang, M; Yang, P; Zhao, R; Zheng, X; Zheng, Y; Zhou, S, 2012) |
| "Renal Insufficiency Following Radiocontrast Exposure demonstrates a homogeneously low rate of CIN after exposure to nonionic, iso-osmolar iodixanol regardless of the use of either bicarbonate sodium or sodium chloride solution for volume supplementation." | 5.13 | Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. ( Adolph, E; Chatterjee, T; Holdt-Lehmann, B; Ince, H; Koerber, T; Nienaber, CA; Paschka, S; Prott, A; Schneider, H; Schuff-Werner, P; Steiner, M, 2008) |
| " We investigated to determine whether simvastatin pretreatment reduces the risk of contrast-induced nephropathy in a high-risk population of patients with renal insufficiency undergoing coronary angiography." | 5.13 | Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study. ( Chae, IH; Cho, YS; Choi, DJ; Choi, YS; Chung, WY; Jo, SH; Kang, HJ; Kim, HS; Kim, YJ; Koo, BK; Oh, BH; Park, JS; Park, YB; Sohn, DW; Youn, TJ, 2008) |
| " The present study was aimed at determining the risk of tubular nephrotoxicity in patients with mild to moderate renal insufficiency who underwent intravenous urography (IVU) with the nonionic dimeric contrast agent iodixanol (Visipaque, Nycomed Imaging, Oslo, Norway)." | 5.08 | Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial. ( Antonione, R; Assante, M; Carraro, M; Cova, M; Faccini, L; Grynne, B; Haider, T; Malalan, F; Palma, LD; Petz, S; Stacul, F, 1998) |
| " This double blind, comparative, randomized, parallel trial compared the efficacy of iodixanol (non-ionic dimer) and iopromide (non-ionic monomer) in 100 patients with mild to moderate renal insufficiency (serum creatinine of 135 to 265 mumol l-1) who underwent i." | 5.08 | Comparison between the efficacy of dimeric and monomeric non-ionic contrast media (iodixanol vs iopromide) in urography in patients with mild to moderate renal insufficiency. ( Assante, M; Cova, M; Haider, T; Hougens Grynne, B; Stacul, F, 1998) |
| " The objective of our meta-analysis was to compare the clinical safety of iso-osmolar contrast medium iodixanol to low-osmolar contrast medium iopromide in patients with renal insufficiency undergoing coronary angiography with or without percutaneous coronary intervention (PCI)." | 4.98 | Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI. ( Chen, M; Jiang, Y; Rui, Q; Yang, H; Zhang, J; Zhang, N; Zhou, Y, 2018) |
| "Iodixanol better preserves short- and long-term renal outcomes in patients with severe baseline renal insufficiency." | 3.73 | Iso-osmolar contrast medium better preserves short- and long-term renal function after cardiovascular catheterizations in patients with severe baseline renal insufficiency. ( Chen, YT; Her, HY; Hsieh, YC; Lee, WL; Liang, KW; Lin, WW; Liu, TJ; Ting, CT; Wang, KY, 2006) |
| "Gadolinium contrast is a potential alternative to iodinated contrast for percutaneous transluminal renal angioplasty (PTRA), and appears to be safe and well tolerated." | 1.35 | Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. ( Garovic, VD; Kalnicka, D; Kane, GC; Lee, CU; Rosenthal, DW; Stanson, AW; Textor, SC, 2008) |
| "Iohexol-treated patients had a similar low risk for developing clinically significant renal failure (0." | 1.33 | Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. ( Hansell, P; Lagerqvist, B; Liss, P; Persson, PB, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y | 1 |
| Qiu, G | 1 |
| Xu, C | 1 |
| Duan, Z | 1 |
| Wang, M | 2 |
| Wang, L | 2 |
| Hu, W | 1 |
| Li, P | 1 |
| Zhou, H | 1 |
| Qian, G | 1 |
| Yang, YQ | 1 |
| Dong, W | 1 |
| Cao, F | 1 |
| Chen, YD | 1 |
| Zhang, J | 1 |
| Jiang, Y | 1 |
| Rui, Q | 1 |
| Chen, M | 1 |
| Zhang, N | 1 |
| Yang, H | 1 |
| Zhou, Y | 1 |
| Peng, M | 1 |
| Jiang, XJ | 1 |
| Dong, H | 1 |
| Zou, YB | 1 |
| Song, L | 1 |
| Zhang, HM | 1 |
| Wu, HY | 1 |
| Yang, YJ | 1 |
| Gao, RL | 1 |
| Adolph, E | 1 |
| Holdt-Lehmann, B | 1 |
| Chatterjee, T | 1 |
| Paschka, S | 1 |
| Prott, A | 1 |
| Schneider, H | 1 |
| Koerber, T | 1 |
| Ince, H | 1 |
| Steiner, M | 1 |
| Schuff-Werner, P | 1 |
| Nienaber, CA | 1 |
| From, AM | 1 |
| Al Badarin, FJ | 1 |
| McDonald, FS | 1 |
| Bartholmai, BJ | 1 |
| Cha, SS | 1 |
| Rihal, CS | 1 |
| Briguori, C | 2 |
| Visconti, G | 1 |
| Ricciardelli, B | 2 |
| Condorelli, G | 1 |
| Shin, DH | 1 |
| Choi, DJ | 3 |
| Youn, TJ | 4 |
| Yoon, CH | 1 |
| Suh, JW | 1 |
| Kim, KI | 1 |
| Cho, YS | 3 |
| Cho, GY | 1 |
| Chae, IH | 3 |
| Kim, CH | 1 |
| Chen, Y | 1 |
| Hu, S | 1 |
| Liu, Y | 1 |
| Zhao, R | 1 |
| Fu, G | 1 |
| He, Q | 1 |
| Su, X | 1 |
| Zheng, Y | 1 |
| Qi, X | 1 |
| Liu, H | 1 |
| Wang, J | 1 |
| Gao, W | 1 |
| Liu, S | 1 |
| Zheng, X | 1 |
| He, B | 1 |
| Yang, P | 1 |
| Zhou, S | 1 |
| Gao, C | 1 |
| Qiu, C | 1 |
| Smith, D | 1 |
| Chudgar, A | 1 |
| Daly, B | 1 |
| Cooper, M | 1 |
| Baker, CS | 1 |
| Wragg, A | 1 |
| Kumar, S | 1 |
| De Palma, R | 1 |
| Baker, LR | 1 |
| Knight, CJ | 1 |
| Petrik, M | 1 |
| Weigel, C | 1 |
| Kirsch, M | 1 |
| Hosten, N | 1 |
| Gupta, R | 1 |
| Uretsky, BF | 1 |
| Heinrich, M | 1 |
| Uder, M | 1 |
| Hsieh, YC | 1 |
| Liu, TJ | 1 |
| Liang, KW | 1 |
| Her, HY | 1 |
| Lin, WW | 1 |
| Wang, KY | 1 |
| Chen, YT | 1 |
| Ting, CT | 1 |
| Lee, WL | 1 |
| Jo, SH | 3 |
| Koo, BK | 3 |
| Park, JS | 2 |
| Kang, HJ | 2 |
| Chung, WY | 2 |
| Joo, GW | 1 |
| Oh, BH | 2 |
| Lee, MM | 1 |
| Park, YB | 2 |
| Kim, HS | 3 |
| Liss, P | 1 |
| Persson, PB | 1 |
| Hansell, P | 1 |
| Lagerqvist, B | 1 |
| Airoldi, F | 1 |
| D'Andrea, D | 1 |
| Bonizzoni, E | 1 |
| Morici, N | 1 |
| Focaccio, A | 1 |
| Michev, I | 1 |
| Montorfano, M | 1 |
| Carlino, M | 1 |
| Cosgrave, J | 1 |
| Colombo, A | 1 |
| Kane, GC | 1 |
| Stanson, AW | 1 |
| Kalnicka, D | 1 |
| Rosenthal, DW | 1 |
| Lee, CU | 1 |
| Textor, SC | 1 |
| Garovic, VD | 1 |
| Kim, YJ | 1 |
| Sohn, DW | 1 |
| Choi, YS | 1 |
| Nossen, JO | 1 |
| Jakobsen, JA | 1 |
| Kjaersgaard, P | 1 |
| Andrew, E | 1 |
| Jacobsen, PB | 1 |
| Berg, KJ | 1 |
| Carraro, M | 1 |
| Malalan, F | 1 |
| Antonione, R | 1 |
| Stacul, F | 3 |
| Cova, M | 2 |
| Petz, S | 1 |
| Assante, M | 2 |
| Grynne, B | 1 |
| Haider, T | 2 |
| Palma, LD | 1 |
| Faccini, L | 1 |
| Hougens Grynne, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| BIcarbonato di Sodio e N-Acetilcisteina Nella Prevenzione Della Nefropatia da Mezzo di Contrasto Nell'infaRto mIocardico acutO(Registro BINARIO)[NCT01218178] | 520 participants (Actual) | Observational | 2008-06-30 | Completed | |||
| Renal Insufficiency Following Contrast Media Administration Trial II (Remedial II): The RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury[NCT01098032] | Phase 3 | 294 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| Chinese People's Liberation Army General Hospital[NCT02718521] | 400 participants (Anticipated) | Interventional | 2016-03-31 | Active, not recruiting | |||
| A Randomized, Double-blinded Comparison of Iopromide and Iodixanol in Renally Impaired Patients Undergoing Cardiac Catheterization[NCT00926562] | Phase 4 | 592 participants (Actual) | Interventional | 2009-02-28 | Completed | ||
| N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients[NCT00780962] | Phase 2 | 399 participants (Actual) | Interventional | 2007-10-16 | Completed | ||
| N-acetylcysteine to Prevent Renal Failure in Patients With Chronic Kidney Disease Undergoing Coronary Artery Bypass Surgery[NCT01359722] | 50 participants (Anticipated) | Interventional | 2010-03-31 | Recruiting | |||
| Pre-existing Microalbuminuria Predicting Contrast-induced Acute Kidney Injury (CIAKI) Following Coronary Angiography (CAG)[NCT02808845] | 800 participants (Anticipated) | Observational | 2016-12-31 | Not yet recruiting | |||
| Renal Toxicity Evaluation and Comparison Between Visipaque (Iodixanol) and Hexabrix (Ioxaglate) in Renal Insufficiency Undergoing Coronary Angiography: The RECOVER Study, A Randomized Controlled Trial[NCT00247325] | Phase 4 | 0 participants | Interventional | 2004-01-31 | Completed | ||
| The Prevention Contrast-Induced Acute Kidney Injury With the Triple Combination of Hydration With Physiological Saline, N-Acetylcysteine and Sodium Bicarbonate[NCT01210456] | Phase 3 | 458 participants (Anticipated) | Interventional | 2009-10-31 | Enrolling by invitation | ||
| Efficacy of Oral Sodium Chloride vs iv Sodium Chloride in the Prevention of Contrast Nephropathy in Outpatients[NCT03476460] | Phase 2 | 269 participants (Actual) | Interventional | 2014-03-01 | Completed | ||
| Prevention of Radiocontrast Media Induced Nephropathy by Short-Term High-Dose Statin in Renal Insufficiency Undergoing Coronary Angiography (PROMISS)[NCT00259441] | Phase 4 | 320 participants | Interventional | 2005-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary outcome measure will be the rate of development of CI-AKI in the 2 study arms (number of participants). CI-AKI is defined as an increase in the serum creatinine concentration >=0.3 mg/dL from the baseline value at 48 hours after administration of the contrast media or the need for dialysis. (NCT01098032)
Timeframe: at 48 hours following contrast exposure
| Intervention | participants (Number) |
|---|---|
| Systemic Alone Therapy Group | 146 |
| RenalGuard System Group | 146 |
Contrast-induced nephropathy was defined as an increase in serum creatinine level of greater than or equal to 0.5 mg/dL or an increase of 25% above baseline. The primary outcome was measured by the change in serum creatinine level from the pre-radiocontrast baseline to the serum creatinine level measured 48 to 72 hours after radiocontrast administration. (NCT00780962)
Timeframe: 48-72 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| N-Acetycysteine Group | 14 |
| 0.9% Sodium-chloride Group | 12 |
4 reviews available for iodixanol and Renal Insufficiency
| Article | Year |
|---|---|
Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis.
Topics: Contrast Media; Creatinine; Female; Humans; Iohexol; Kidney Diseases; Male; Renal Insufficiency; Ret | 2022 |
Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
Topics: Contrast Media; Coronary Angiography; Creatinine; Humans; Iohexol; Kidney Diseases; Percutaneous Cor | 2018 |
Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
Topics: Contrast Media; Coronary Angiography; Coronary Artery Disease; Diatrizoate Meglumine; Humans; Incide | 2010 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast | 2011 |
12 trials available for iodixanol and Renal Insufficiency
| Article | Year |
|---|---|
Comparison of Iodixanol and Iopromide in Patients With Renal Insufficiency and Congestive Heart Failure Undergoing Coronary Angiography by Hemodynamic Monitoring.
Topics: Contrast Media; Coronary Angiography; Female; Heart Failure; Hemodynamic Monitoring; Humans; Iohexol | 2017 |
Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Coronary Disease; Double-Blind | 2008 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast | 2011 |
Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Creatinine; Double-Blind | 2011 |
Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
Topics: Aged; Biomarkers; Cardiac Catheterization; China; Contrast Media; Coronary Angiography; Coronary Art | 2012 |
Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
Topics: Aged; Biomarkers; Cardiac Catheterization; China; Contrast Media; Coronary Angiography; Coronary Art | 2012 |
Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
Topics: Aged; Biomarkers; Cardiac Catheterization; China; Contrast Media; Coronary Angiography; Coronary Art | 2012 |
Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
Topics: Aged; Biomarkers; Cardiac Catheterization; China; Contrast Media; Coronary Angiography; Coronary Art | 2012 |
A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.
Topics: Acetylcysteine; Aged; Cardiac Catheterization; Clinical Protocols; Contrast Media; Creatinine; Drug | 2003 |
A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.
Topics: Acetylcysteine; Aged; Cardiac Catheterization; Clinical Protocols; Contrast Media; Creatinine; Drug | 2003 |
A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.
Topics: Acetylcysteine; Aged; Cardiac Catheterization; Clinical Protocols; Contrast Media; Creatinine; Drug | 2003 |
A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.
Topics: Acetylcysteine; Aged; Cardiac Catheterization; Clinical Protocols; Contrast Media; Creatinine; Drug | 2003 |
Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Topics: Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Ioxaglic Acid; Male; Middle | 2006 |
Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Topics: Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Ioxaglic Acid; Male; Middle | 2006 |
Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Topics: Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Ioxaglic Acid; Male; Middle | 2006 |
Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Topics: Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Ioxaglic Acid; Male; Middle | 2006 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.
Topics: Administration, Oral; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Dose-Response Re | 2008 |
Elimination of the non-ionic X-ray contrast media iodixanol and iohexol in patients with severely impaired renal function.
Topics: Aged; Body Weight; Contrast Media; Creatinine; Double-Blind Method; Feces; Glomerular Filtration Rat | 1995 |
Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial.
Topics: Acetylglucosaminidase; Adult; Aged; Aged, 80 and over; Albuminuria; Alpha-Globulins; CD13 Antigens; | 1998 |
Comparison between the efficacy of dimeric and monomeric non-ionic contrast media (iodixanol vs iopromide) in urography in patients with mild to moderate renal insufficiency.
Topics: Adult; Aged; Contrast Media; Double-Blind Method; Female; Humans; Iohexol; Male; Middle Aged; Observ | 1998 |
10 other studies available for iodixanol and Renal Insufficiency
| Article | Year |
|---|---|
A Comparison of Nephrotoxicity of Contrast Medium in Elderly Patients who Underwent Renal or Peripheral Arterial Vascular Intervention.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Contrast Media; Coronary Angiography; Creatini | 2016 |
Evaluation of potential renal transplant recipients with computed tomography angiography.
Topics: Adult; Aged; Angiography; Contrast Media; Cost-Benefit Analysis; Female; Humans; Kidney Transplantat | 2012 |
[No detectable nephrotoxic side effect using a dimer, non-ionic contrast media in cerebral perfusion computed tomography in case of suspected brain ischemia].
Topics: Aged; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Contrast Media; Creatinine; | 2005 |
Gadodiamide-based coronary angiography in a patient with severe renal insufficiency.
Topics: Contrast Media; Coronary Angiography; Gadolinium DTPA; Humans; Kidney; Male; Middle Aged; Renal Insu | 2005 |
Nephrotoxicity of low-osmolar and iso-osmolar contrast media.
Topics: Contrast Media; Humans; Iohexol; Iopamidol; Kidney; Osmolar Concentration; Renal Insufficiency; Trii | 2006 |
Iso-osmolar contrast medium better preserves short- and long-term renal function after cardiovascular catheterizations in patients with severe baseline renal insufficiency.
Topics: Cardiac Catheterization; Contrast Media; Female; Humans; Kidney; Male; Osmolar Concentration; Prospe | 2006 |
Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Creatinine; Dialysis; Fe | 2006 |
Iodixanol vs ioxaglate for preventing contrast nephropathy: who is winner?
Topics: Contrast Media; Humans; Ioxaglic Acid; Renal Insufficiency; Research Design; Risk Factors; Triiodobe | 2007 |
Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes.
Topics: Aged; Angiography, Digital Subtraction; Angioplasty, Balloon; Atherosclerosis; Contrast Media; Creat | 2008 |
Evaluation of renal function following administration of nonionic dimers.
Topics: Acetylglucosaminidase; Angiography; CD13 Antigens; Contrast Media; Creatinine; Follow-Up Studies; Gl | 1999 |